← All trials
NCT04957095
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 18, 2022
- Primary completion
- Dec 1, 2027
- Completion date
- Dec 1, 2028
- First posted
- Jul 12, 2021
- Last posted
- Aug 9, 2024
- Enrollment
- 120
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- The University of Texas, DallasLead sponsor
- The University of Texas, DallasOfficial
- National Institute of Neurological Disorders and Stroke (NINDS)Collaborator
- The University of Texas, DallasSponsor investigator
- University of California, Los AngelesCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.